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Background. Enteric fever, a bacterial infection caused by Salmonella enterica serotypes Typhi and Paratyphi A, frequently 
presents as a nonlocalizing febrile illness that is difficult to distinguish from other infectious causes of fever. Blood culture is not 
widely available in endemic settings and, even when available, results can take up to 5 days. We evaluated the diagnostic perfor-
mance of clinical features, including both reported symptoms and clinical signs, of enteric fever among patients participating in the 
Surveillance for Enteric Fever in Asia Project (SEAP), a 3-year surveillance study in Bangladesh, Nepal, and Pakistan.
Methods. Outpatients presenting with ≥3 consecutive days of reported fever and inpatients with clinically suspected enteric 
fever from all 6 SEAP study hospitals were eligible to participate. We evaluated the diagnostic performance of select clinical features 
against blood culture results among outpatients using mixed-effect regression models with a random effect for study site hospital. We 
also compared the clinical features of S. Typhi to S. Paratyphi A among both outpatients and inpatients.
Results. We enrolled 20 899 outpatients, of whom 2116 (10.1%) had positive blood cultures for S. Typhi and 297 (1.4%) had 
positive cultures for S. Paratyphi A. The sensitivity of absence of cough was the highest among all evaluated features, at 65.5% (95% 
confidence interval [CI], 55.0–74.7), followed by measured fever at presentation at 59.0% (95% CI, 51.6–65.9) and being unable to 
complete normal activities for 3 or more days at 51.0% (95% CI, 23.8–77.6). A combined case definition of 3 or more consecutive 
days of reported fever and 1 or more of the following (a) either the absence of cough, (b) fever at presentation, or (c) 3 or more con-
secutive days of being unable to conduct usual activity--yielded a sensitivity of 94.6% (95% CI, 93.4–95.5) and specificity of 13.6% 
(95% CI, 9.8–17.5).
Conclusions. Clinical features do not accurately distinguish blood culture–confirmed enteric fever from other febrile syndromes. 
Rapid, affordable, and accurate diagnostics are urgently needed, particularly in settings with limited or no blood culture capacity.
Keywords.  Enteric fever; typhoid; South Asia; clinical diagnosis.
Enteric fever is a systemic bacterial infection caused by 
Salmonella enterica subspecies enterica serotypes Typhi and 
Paratyphi. Estimates of enteric fever incidence range from 
550 per 100 000 in South Asia to 160 per 100 000 in Western 
sub-Saharan Africa to 0.3 per 100 000 in Western Europe [1].
Typhoid and Paratyphoid commonly cause nonlocalizing fe-
brile illnesses that present similarly to many other bacterial, viral, 
and parasitic fevers. Physicians have struggled to distinguish 
enteric fever from other fever etiologies for hundreds of years, 
potentially even as early as the era of Hippocrates [2–4]. While 
the advent of bacterial culturing techniques in the early 20th cen-
tury improved the accuracy of diagnosing enteric fever, the cost 
and logistical hurdles of setting up microbiology facilities put 
them largely out of reach for many of the regions with the highest 
enteric fever burden [5]. Even when blood culture capacity is 
available, testing can be costly, has limited sensitivity, and is slow, 
with results taking up to 5 days [6]. For these reasons, physicians 
managing patients with enteric fever in low- and middle-income 
countries often rely on clinical features, including both reported 
symptoms and clinical signs to make diagnoses and choose treat-
ment regimens.
Despite the reliance of clinicians on clinical features to diagnose 
enteric fever, accurate clinical prediction rules have remained elu-
sive [7–9]. We evaluated the diagnostic performance of clinical 
features of blood culture–confirmed S. Typhi and S. Paratyphi 







ent_3/S257/6013564 by Aga Khan U
niversity, H
ealth Sciences Library user on 26 January 2021
S258 • cid 2020:71 (Suppl 3) • Aiemjoy et al
Project (SEAP), conducted in Bangladesh, Nepal, and Pakistan. 
We also compared the clinical features of S. Typhi patients to S. 
Paratyphi A patients. Our objectives were to identify those clin-
ical features that might have diagnostic value for identifying enteric 
fever and that might distinguish S. Paratyphi A from S. Typhi.
METHODS
Study Design Overview
SEAP was a prospective surveillance study for enteric fever in 
Bangladesh, Nepal, and Pakistan. Participants were enrolled 
from September 2016 through September 2019. In each country, 
there were 2 SEAP enrollment hospitals; the facility coverage 
was urban for Bangladesh (Dhaka) and Pakistan (Karachi), and 
both urban (Kathmandu) and peri-urban (Kavre) in Nepal. 
Participants were enrolled from outpatient and inpatient de-
partments, as well as from the hospital laboratory. Both study 
sites in Bangladesh served a primarily pediatric population.
Study Population
To evaluate those clinical symptoms that might distinguish en-
teric fever (S. Typhi or S. Paratyphi) from other febrile illnesses, 
we included all SEAP participants recruited from outpatient de-
partments. Outpatient department participants were individuals 
living in the predefined catchment area of the hospital who pre-
sented to the study facility outpatient department with 3 or more 
consecutive days of fever and received a blood culture [10].
To compare the clinical features of S. Typhi to S. Paratyphi, 
we included SEAP participants recruited from the inpatient 
and outpatient departments, and from the hospital laboratory. 
For this analysis, we included individuals who presented to the 
outpatient department with 3 or more consecutive days of re-
ported fever and received a blood culture; individuals presenting 
to the inpatient department with clinically suspected enteric 
fever, with or without blood culture; or individuals presenting 
to the inpatient department or hospital laboratory with a blood 
culture–confirmed S. Typhi or S. Paratyphi infection. Individuals 
presenting to outpatient departments were only eligible if they 
resided within the predefined catchment area, whereas individ-
uals presenting to inpatient departments or the hospital lab were 
eligible regardless of their residential address. The days of fever 
criteria were measured by self-report or caregiver-report.
Measurements
A sample of peripheral venous blood was collected from each 
study participant in either a BD BACTEC (TM) or BD BACTEC 
PEDS Plus (TM) aerobic bottle and incubated for up to 5 days, 
using the BACTEC automated culture system (BACTEC; Becton 
Dickinson, Baltimore, MD). Indicator-positive samples were then 
subcultured onto MacConkey agar plates and nonselective media 
(sheep blood agar). Species were confirmed using biochemical 
testing and O and H antisera (BD Laboratories), if available.
Research assistants reviewed hospital records and entered 
information on physical exam findings and additional labo-
ratory test results into a custom-built, electronic data-capture 
system. Complete blood count results were only available from 
participants for whom the test was indicated and performed. 
Temperature was assessed on arrival to the outpatient depart-
ment or upon admission to the inpatient department. Fever start 
date, days of being unable to conduct normal activity, cough, 
diarrhea, constipation, abdominal pain, vomiting, nausea, and 
headache were all measured using self-r or caregiver-report and 
were collected directly from the patient or guardian at the time 
of enrollment into SEAP. We also recorded the clinician’s assess-
ment of whether the patient had enteric fever, which was made 
before blood culture results were available.
Statistical Analyses
We evaluated associations and calculated the diagnostic perfor-
mance of clinical features using mixed-effect logit models with a 
random effect for study site hospital, adjusted for age. Sensitivity 
and specificity were calculated as the probability of the dichoto-
mous result of the index test (ie, clinical feature), conditional on 
the blood culture being positive (sensitivity) or negative (spec-
ificity). The positive predictive value (PPV) and negative pre-
dictive value were calculated as the probability of blood culture 
positivity, conditional on the index test being positive or negative, 
respectively. We estimated probabilities and standard errors from 
the logit models using the emmeans package (version 1.4.4) in 
R.  We evaluated the top 2 and top 4 performing symptoms in 
combination (performance defined by the sensitivity). We also 
assessed the validity of the clinician’s suspected diagnosis of en-
teric fever, using the same approach both overall and by country.
To compare gastrointestinal symptoms among patients based 
on the blood culture outcome and age strata, we used general-
ized estimating equations that accounted for clustering by study 
site hospital.
To evaluate differences in the clinical features of S. Typhi and 
S. Paratyphi infections, we used mixed-effect regression models 
with a random effect for study site hospital. All variables were 
evaluated in independent models and were adjusted for age 
(with the exception of age itself, gender, and recruitment site). 
All analyses were performed in R studio (R version 3.6.0).
Ethics Statement
Written informed consent was obtained from all partici-
pants. For minors, verbal assent was provided in addition to 
informed consent from a parent or guardian. The study was 
approved by the Bangladesh Institute of Child Health Ethical 
Review Committee, Nepal Health Research Council, Aga Khan 
University Ethical Review Committee, National Bioethics 
Committee of Pakistan, Institutional Review Board at Stanford 
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RESULTS
Enteric Fever Clinical Features Among Patients Presenting to Outpatient 
Departments with Three or More Consecutive Days of Reported Fever
Over the 3-year study period, we enrolled 20 899 patients 
with ≥3  days of reported  fever from outpatient departments. 
All patients received a blood culture, yielding 2116 (10.1%) S. 
Typhi, 297 (1.4%) S. Paratyphi A, and 18 486 (88%) negative 
cultures (Table 1). The median age of enteric fever outpatients 
was 6 years (5 in Bangladesh, 19 in Nepal, and 6 in Pakistan), 
compared with 5 years among non–enteric fever patients (3 in 
Bangladesh, 19 in Nepal, and 8 in Pakistan).
At presentation to the outpatient department, 1321 (59%) 
enteric fever patients were febrile (>99.5°F), compared with 
7437 (44%) blood culture–negative febrile patients; 109 (4.8%) 
of the enteric fever patients had a high-grade fever (≥103°F), 
compared with 421 (2.5%) of the blood culture–negative febrile 
patients (Table 1). The median temperature upon presentation 
to the outpatient department was higher among both S. Typhi 
and S. Paratyphi A patients than among non–enteric fever pa-
tients across all age groups (Figure 1). The mean temperature 
upon presentation was 100.7 °F for patients who were blood 
culture positive for enteric fever and 99.6 °F for patients who 
were blood culture negative for enteric fever (P < .00001)
The most commonly reported symptoms were similar among 
enteric fever patients and enteric fever culture-negative pa-
tients, though enteric fever patients were less likely to report 
cough or headache than culture-negative febrile patients, but 
more likely to report abdominal pain, vomiting, or diarrhea 
(Table  1). The presentation of abdominal pain, diarrhea, and 
vomiting among enteric fever patients was age dependent. 
Adults (>25  years) with enteric fever were more likely to re-
port abdominal pain than febrile adults without enteric fever. 
Diarrhea was more common in young children (<2 years) with 
S. Paratyphi A, and among adults (>25 years) with S. Typhi and 
S. Paratyphi A. Constipation did not have an age-dependent re-
lationship (Figure 2). Patients in Nepal and Pakistan were more 
likely to report cough, abdominal pain, and headache as com-
pared to patients in Bangladesh, even after accounting for the 
age differences in the populations (Table 2). In the age-adjusted 
analysis, fever (>99.5o F) at presentation, duration of fever ≥7 
Table 1. Demographic and clinical characteristics of outpatients with 
reported fever ≥3 days, by enteric fever blood culture result -- Bangladesh, 
Nepal, and Pakistan, 2016-2019 
Enteric Fever (+), 
n = 2413
Enteric Fever (−), 
n = 18 486
Female 1057 (43.8%) 8105 (43.8%)
Age, years
 Median (IQR) 6 (3–10) 5 (2–14)
Febrile at presentation, >99.5°F 1321 (58.5%) 7437 (44.4%)
High-grade fever at presenta-
tion, ≥103°F
109 (4.8%) 421 (2.5%)
Temperature at presentation, °F
 Median (IQR) 100 (98.6–101.0) 99.2 (98.1–100.4)
Days of fever
 Mean (SD) 5.6 (3.1) 5.2 (3.0)
Days unable to conduct usual activity
 Mean (SD) 3.1 (3.3) 2.7 (3.0)
Cough 722 (29.9%) 9623 (52.1%)
Diarrhea 386 (16.0%) 2159 (11.7%)
Constipation 135 (5.6%) 1289 (7.0%)
Abdominal pain 626 (26.0%) 3677 (20.1%)
Vomiting 760 (31.5%) 5095 (27.6%)
Nausea 14 (.6%) 282 (1.5%)
Headache 620 (25.9%) 5581 (30.8%)
Leukopenia 72 (9.2%) 710 (13.0%)
Thrombocytopenia 70 (8.9%) 628 (11.5%)
Diagnosed with enteric fever 1678 (69.6%) 7961 (43.1%)
Data are of outpatients presenting with 3 or more consecutive days of fever to SEAP study 
site facilities Bangladesh, Nepal, and Pakistan based on their enteric fever (Salmonella 
Typhi or Salmonella Paratyphi) blood culture result. 
Abbreviations: IQR, interquartile range; SD, standard deviation. 
Figure 1. Distribution of temperature at presentation among 20 899 outpatients 
presenting with 3 or more consecutive days of reported fever to SEAP study site 
hospitals in Bangladesh, Nepal, and Pakistan. The solid black vertical lines indicate 
the median intake temperature. Abbreviation: EF negative, blood culture negative 
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Figure 2. Gastrointestinal symptoms among outpatients with 3 or more consecutive days of fever to SEAP study site hospitals in Bangladesh, Nepal, and Pakistan. Point 
estimates and confidence intervals were calculated using generalized estimating equations to account for clustering by study site hospital. Abbreviations: EF negative, blood 
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days, headache, absence of cough, and inability to conduct 
usual activities ≥3 days, as well as abdominal pain, diarrhea and 
vomiting were associated with enteric fever (Figure 3).
The sensitivity and specificity of using fever (>99.5°F) at pre-
sentation as a diagnostic criterion were 59.0% (95% confidence 
interval [CI], 51.6–65.9) and 55.9% (95% CI, 48.6–63.3), respec-
tively; the PPV was 13.1% (95% CI, 9.3–18.2; Table 4). The sensi-
tivity of absence of cough was the highest among all the clinical 
features evaluated, at 65.5% (95% CI, 55.0–74.7), followed by fever 
(>99.5°F) at presentation at 59.0% (95% CI, 51.6–65.9), and then 
by having 3 or more days of being unable to conduct activity at 
51.0% (95% CI, 23.8–77.56). Even though abdominal pain, head-
ache, diarrhea, vomiting, and duration of fever (≥7 days) were 
all positively associated with enteric fever in the age-adjusted 
analysis (Figure 3), the sensitivities for these symptoms did not 
surpass 35%. For the combined case definition of 3 or more con-
secutive days of reported fever and one or more of the following 
-- (a) absence of cough, (b) fever at presentation, (c) 3 or more 
days of being unable to conduct usual activity, the sensitivity was 
94.6% (95% CI, 93.4–95.5) and the specificity was 13.6% (95% CI, 
9.8–17.5). The PPV was just 10.5% (95% CI, 7.2–15.0), and did 
not exceed the enteric fever blood culture–positive prevalence in 
either Pakistan (14.3%) or Bangladesh (13.2%; Table 3).
Comparison of Salmonella Typhi and Paratyphi A  Clinical Signs and 
Symptoms
In addition to outpatients, we enrolled S. Typhi and S. Paratyphi 
A blood culture–positive patients from inpatient departments 
and the hospital lab, resulting in a total of 4610 patients with S. 
Typhi and 605 with S. Paratyphi A. Overall, S. Paratyphi A com-
prised 11.6% (605/ 5215) of enteric fever cases, including 12.8% 
(387/3032) in Bangladesh, 19.3% (103/533) in Nepal, and 7.0% 
(115/1650) in Pakistan.
Individuals with microbiologically confirmed S. Typhi were 
younger than S.  Paratyphi A patients (mean age 11.5 versus 13.5 
years, p<0.001). Patients with S. Typhi were more likely to be ad-
mitted to an inpatient department than those with S. Paratyphi 
A  (20.8% vs 12.7%, respectively; P < .001);  and  S. Typhi pa-
tients were more likely to be both febrile (>99.5°F) and present 
with a high-grade fever (≥103°F) at their initial clinical presen-
tation compared with patients with S. Paratyphi A. Abdominal 
pain, diarrhea and vomiting were more frequently reported by 
patients with S. Typhi than those with S. Paratyphi A (Table 4).
DISCUSSION
The diagnostic performance of clinical features , both re-
ported symptoms and clinical signs,  to distinguish enteric 
fever from other causes of febrile illness was moderate in this 
large, multi-country, multi-site study of febrile patients pre-
senting to outpatient departments. The findings indicate that 
clinical presentation cannot be used to reliably screen febrile 
patients for further diagnostic testing. Our findings underline 
the need for accurate, rapid, and affordable diagnostics, par-
ticularly in low-resource settings where blood culture is typi-
cally not available.
Table 2. Characteristics of outpatients aged ≤15 years with blood-culture confirmed enteric fever, by study country — Bangladesh, Nepal, and Pakistan, 
2016–2019
Bangladesh, n = 1448 Nepal, n = 77 Pakistan, n = 542
Female 665 (45.9%) 28 (36.4%) 240 (44.3%)
Age in years
 Mean (SD) 5.2 (2.9) 9.1 (3.7) 5.2 (3.8)
Febrile at presentation, >99.5°F 802 (57.2%) 28 (54.9%) 314 (58.4%)
High-grade fever at presentation, ≥103°F 59 (4.2%) 1 (2.0%) 20 (3.7%)
Temperature at presentation, °F
 Mean (SD) 99.8 (1.7) 99.7 (2.0) 100.0 (1.7)
Days of fever
 Mean (SD) 5.3 (2.7) 5.4 (3.0) 6.2 (3.6)
Days unable to conduct usual activity
 Mean (SD) 2.1 (2.6) 4.3 (3.1) 4.2 (3.6)
Cough 299 (20.7%) 34 (44.2%) 242 (44.6%)
Diarrhea 169 (11.7%) 15 (19.5%) 120 (22.2%)
Constipation 72 (5.0%) 2 (2.6%) 33 (6.1%)
Abdominal pain 211 (14.6%) 37 (48.1%) 229 (42.6%)
Vomiting 293 (20.2%) 33 (42.9%) 273 (50.4%)
Nausea 1 (.1%) 3 (3.9%) 1 (.2%)
Headache 73 (5.0%) 43 (57.3%) 202 (38.3%)
Leukopenia 10 (2.4%) 3 (7.1%) 19 (13.1%)
Thrombocytopenia 7 (1.7%) 4 (9.5%) 21 (14.5%)
Diagnosed with enteric fever 1127 (77.8%) 42 (54.5%) 359 (66.2%)
Data are from outpatient children 15 years and younger with blood culture–confirmed enteric fever. 
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In this study, blood culture–positive S. Typhi and S. Paratyphi 
A  patients had, on average, a 1-degree higher temperature at 
presentation when compared with febrile enteric fever blood 
culture–negative patients; being febrile (>99.5°F) and having 
a high-grade fever (≥ 103°F) at presentation were predictive 
of both S. Typhi and S. Paratyphi A  blood culture positivity. 
Whether this finding would hold in settings with other endemic 
febrile illnesses, such as malaria, warrants further exploration. 
Constipation and a mild cough are taught to be common in en-
teric fever patients [11–13]. We did find that around a third of 
Figure 3. Comparison of the characteristics of Salmonella Typhi, Salmonella Paratyphi, and enteric fever (Salmonella Typhi or Salmonella Paratyphi) among 20 899 out-
patients presenting with 3 or more consecutive days of fever to SEAP study site hospitals in Bangladesh, Nepal, and Pakistan. Odds ratios and 95% confidence intervals 
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the patients with S. Typhi and S. Paratyphi A reported a cough; 
however, when compared to febrile enteric fever blood culture–
negative patients, the relative importance of cough diminished. 
On the contrary, the absence of a cough was predictive of both 
S. Typhi and S. Paratyphi A  culture positivity. Constipation 
was not common in this study population. Unlike studies by 
Hosoglu et al. [7], Haq et al [9], Kuvandik et al [14], and Khan 
et al [15], we did not see an association between leukopenia and 
enteric fever. However, complete blood counts were not sys-
tematically collected as part of the study protocol, so this study 
could not systematically evaluate the predictive performance of 
the presence of leukopenia.
While gastrointestinal symptoms were comparable in 
younger age groups, adults with enteric fever were more likely 
to report abdominal pain, diarrhea, and vomiting  than blood 
culture–negative febrile patients. These findings suggest that 
gastrointestinal symptoms among adults with 3 or more con-
secutive days of fever may raise the clinical suspicion of typhoid 
and paratyphoid.
While clinical symptoms and features, both alone and in 
combination, were insufficient to diagnose enteric fever, the 
index of suspicion should be raised in outpatient settings for 
patients who present with reported fever for ≥3 days, and who 
have one or more of the following: fever at presentation, no 
cough, or three or more days of being unable to conduct normal 
activities. These findings agree with those of Vollaard et al [8], 
who also reported that clinical symptoms were insufficient to 
diagnose enteric fever in Indonesia, and found that the absence 
of cough should raise clinical suspicion for the disease.
While it is classically taught that S. Paratyphi causes milder 
disease than S. Typhi, several recent epidemiologic studies have 
found no clinically distinguishing features between the 2 sero-
vars [8, 16–18]. We found that patients with S. Paratyphi A pre-
sented with slightly milder symptoms, encompassing fewer days 
of fever, a lower temperature at presentation/admission, and 
fewer gastrointestinal symptoms, including abdominal pain, 
diarrhea and vomiting, compared with patients with S. Typhi. 
These findings contrast with those of Vollaard et  al [8], Patel 
et al [17], and Maskey et al [18], who reported no differences in 
the clinical presentation of S. Paratyphi and S. Typhi. However, 
the Vollaard et al [8] and Patel et al [17] studies were likely un-
derpowered to detect differences in clinical presentation, with 
only 92 and 82 enteric fever cases, respectively. In our study, 
patients with S. Typhi were more likely to be hospitalized than 
those with S. Paratyphi A, suggesting that the clinical syndrome 
of S. Paratyphi A is not as severe. This finding is comparable to 
Table 3. Performance of clinical symptoms for diagnosing enteric fever among outpatients with reported fever ≥3 days — Bangladesh, Nepal, and 
Pakistan, 2016–2019
Sensitivity (95% CI) Specificity (95% CI) PPVa (95% CI) NPVa (95% CI)
Clinical signs
 Febrile at presentation, >99.5°F 59.0% (51.6–65.9) 55.9% (48.6–63.3) 13.1% (9.3–18.2) 92.6% (89.4–95.8)
 High-grade fever at presentation, ≥103°F 5.0% (3.5–7.3) 97.6% (96.4–98.9) 20.5% (16.5–25.1) 90.4% (86.5–94.4)
 Leukopenia 6.3% (3.3–11.6) 88.2% (84.4–92.1) 7.9% (5.0–12.1) 84.5% (69.2–99.7)
 Thrombocytopenia 7.0% (2.8–16.7) 89.5% (82.3–96.6) 7.6% (4.1–13.9) 84.8% (69.1–100.6)
Symptoms
 Absence of cough 65.5% (55.0–74.7) 54.7% (43.5–65.9) 14.2% (10.5–19.0) 93.5% (90.7–96.3)
 ≥3 days of being unable to conduct activity 51.0% (23.8–77.6) 57.1% (27.3–86.9) 10.5% (7.6–14.4) 91.8% (87.4–96.1)
 Vomiting 35.2% (23.3–49.2) 69.8% (54.9–84.8) 11.3% (7.6–16.5) 90.5% (86.8–94.2)
 Headache 33.4% (11.8–65.3) 71.8% (43.5–100.1) 9.1% (6.4–13.0) 91.7% (86.6–96.7)
 Abdominal pain 29.5% (17.3–45.4) 80.0% (66.9–93.0) 12.8% (8.6–18.8) 90.9% (87.5–94.4)
 Fever duration, ≥7 days 24.0% (20.1–28.4) 80.0% (77.5–82.5) 12.7% (9.3–17.3) 89.4% (85.6–93.2)
 Diarrhea 16.8% (10.4–26.1) 88.4% (82.8–94.1) 13.6% (9.8–18.6) 90.5% (86.8–94.2)
 Constipation 4.1% (1.7–9.5) 94.9% (91.1–98.7) 8.1% (5.8–11.1) 89.9% (86.0–93.7)
Combined case definition
 ≥ 3 days of reported fever AND either a) absence of cough OR 
b) fever at presentation (>99.5 °F)
88.0% (83.8–91.1) 30.1% (19.9–40.2) 12.6% (9.0–17.2) 95.6% (93.2–98.1)
 ≥ 3 days of reported fever AND a) Absence of cough OR b) 
measured fever at presentation (>99.5 °F) OR c) ≥ 3 days of 
being unable to conduct activity
94.6% (93.4–95.5) 13.6% (9.8–17.5) 10.5% (7.2–15.0) 97.0% (94.1–100.0)
Multiple symptoms: febrile at presentation, absence of cough, ≥3 days of being unable to conduct activity, vomiting, headache, abdominal pain
 Any 2 of above symptoms 88.0% (77.5–94.0) 27.4% (17.3–37.6) 11.5% (8.0–16.2) 96.1% (92.8–99.4)
 Any 3 of above symptoms 55.5% (37.9–71.8) 64.2% (46.6–81.8) 13.5% (9.6–18.7) 93.5% (89.5–97.5)
 Any 4 of above symptoms 23.4% (10.8–43.3) 87.3% (76.1–98.4) 14.1% (10.3–18.9) 91.6% (87.5–95.6)
Sensitivity, specificity, PPV, and NPV were calculated using mixed-effects logit models with a random effect for study hospital, and were adjusted for age. 
Abbreviations: NPV, negative predictive value; PPV, positive predictive value.
aThe PPV and NPV rely on the underlying prevalence of disease. In this population, the prevalence of blood culture–positive enteric fever was 11.6% (2416/20 899), with prevalences of 13.2% 
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a study in the United States, largely among returned travelers, 
which reported a higher percentage of hospitalizations among 
patients with S. Typhi compared to those with S. Paratyphi [19].
Several limitations should be considered when interpreting 
the results of this study. We conducted the diagnostic evalua-
tion of clinical symptoms and features among outpatients only, 
and the accuracy of such symptoms and features could possibly 
differ in inpatient settings. However, given that the majority of 
enteric fever patients in this region are diagnosed in ambulatory 
settings, the study population is still relevant [20]. The reference 
standard used for the diagnostic evaluation, blood culture, is it-
self imperfectly valid. The sensitivity of blood culture is estimated 
to be 59% [6], implying that 40% of truly positive S. Typhi and 
S. Paratyphi A cases are missed when using this diagnostic crite-
rion. However, we expect that the addition of missed enteric fever 
cases would not have had a tremendous impact on the diagnostic 
accuracy of the reported symptoms. For example, in a scenario 
where all culture-missed enteric fever cases did not have a cough, 
sensitivity for the absence of cough would increase from 65.5% 
to 78.6%. Another limitation of this study is that we did not have 
access to diagnostic test results for patients who were blood cul-
ture–negative for enteric fever. With this information, we could 
have compared the clinical features of enteric fever to alternative 
etiologies of fever, such as dengue and malaria. Despite these lim-
itations, this study had several strengths. To our knowledge, it is 
the only multi-country study evaluating the predictive value of 
clinical features of enteric fever. With the large sample size and 
multi-country generalizability, we were able to evaluate robustly 
the diagnostic value of the clinical features of enteric fever.
In conclusion, our findings add support to the body of liter-
ature demonstrating that relying on clinical features and symp-
toms is insufficient to accurately diagnose enteric fever. The 
challenge of using symptoms to distinguish enteric fever from 
other febrile illnesses is supported by the moderate to poor 
diagnostic performance of clinicians' diagnoses. The results 
highlight the urgent need for rapid, accurate, and affordable 
diagnostics for enteric fever.
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